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There is an increasing awareness of immune cell modulation by antimicrobial peptides. While this process often requires specific receptors for
the peptides involved, several reports point out to a receptor-independent process. The cecropin A–melittin hybrid peptide CA(1–8)M(1–18)
(KWKLFKKIGIGAVLKVLTTGLPALIS-amide) modifies gene expression in the macrophage line RAW 264.7 in the absence of any previous
macrophage priming, suggesting a membrane permeation process. To further analyze the initial steps of this mechanism, we have studied the
interaction of the peptide with these cells. Below 2 AM, CA(1–8)M(1–18) causes a concentration-dependent membrane depolarization partially
reversible with time. At 2 AM, the accumulation of the SYTOX green vital dye is one half of that achieved with 0.05% Triton X-100. The binding
level, as assessed by fluorescein-labeled CA(1–8)M(1–18), varies from 7.7T1.2 to 37.4T3.9106 molecules/cell over a 0.5–4.0 AM
concentration range. Electrophysiological experiments with 0.5 AM CA(1–8)M(1–18), a concentration that triggers maximal NOS2 expression
and minimal toxicity, show a reversible current induction in the RAW 264.7 plasma membrane that is maintained as far as peptide is present. This
activation of the macrophage involves the production of nitric oxide, a metabolite lethal for many pathogens that results from unspecific
membrane permeation by antimicrobial peptides, and represents a new mode of action that may open new therapeutic possibilities for these
compounds against intracellular pathogens.
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Eukaryotic antibiotic peptides (EAPs) are key components
of innate immunity. They are ubiquitous in all pluricellular
organisms, where they act as a first defensive barrier against
invading pathogens [1,2]. Despite their broad structural variety,
most of them share a tendency to adopt amphipathic structures
upon contact with the pathogen and a marked cationic character
[3,4]. For most EAPs, the lethal mechanism consists in the
permeabilization of the pathogen plasma membrane, by
stoichiometric interaction with the acidic phospholipids ex-
posed at the outer leaflet of the membrane. This phospholipid
distribution is specific of prokaryotes and lower eukaryotes, in
contrast with higher eukaryotes where the anionic phospholi-1763 (2006) 110 – 119
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precluding interaction with EAPs [4–6].
Aside from this main function of EAPs as early host defense
components, there is growing evidence for their involvement in
other physiological processes such as chemotaxis, scarification,
angiogenesis or productive interaction with effector cells of the
immune system [7–9]. Some of these newly found roles have
been experimentally elucidated for specific EAPs or closely
related analogues, and involve receptors and signaling pathways
[10] for the target cells under study, even with a different
zoological origin as the EAP assayed [9]. For instance, for the
EAP LL-37 it was conclusively proven that both chemotactic
and angiogenic activities were performed through the G-protein
coupled formyl peptide receptor-like 1 [11], or that the binding
of some human or mouse h-defensins to the CCR6 chemokine
receptor drove a chemotactic response [7]. This is in sharp
contrast with microbicidal effects, which largely involve loose
patterns of pathogen recognition. On the other hand, although
the dogma of preferential permeabilization of pathogen or trans-
formed-cell plasma membrane as the rationale for EAP cellular
specificity remains basically valid, it is challenged by the non-
lethal permeabilization of higher eukaryotic cells by a wide
variety of EAPs, including magainins on non-transformed fibro-
blasts [12], or h-defensin 3 [13] or protegrins [14] on Xenopus
oocytes. These last results, however, were often obtained in the
course of studies on cell permeation by EAPs, hence at peptide/
cell ratios much higher than required for microbicidal activity. In
other cases, however, a real biological function seems to exist for
these permeations, since they were observed at a physiological
range of concentrations for the selected peptide. Examples of
this trend are the permeation of intestinal epithelial cells by
cryptdins, causing chloride [15], and IL-8 [16] secretion, the
vascular permeability induced by the CAP heparin-binding
protein from neutrophils upon its activation through adhesion to
the vascular epithelia [17], or the unspecific permeabilization of
human LPS-primed monocytes by LL-37, leading to the release
of intracellular ATP, which in turn binds into the P2X7
purinergic receptor [18], acting as autocrine or paracrine signal
to these cells to induce IL-1h processing and release.
The cecropin A (CA)–melittin (M) hybrid peptides, in which
the juxtaposition of N-terminal sequences of the insect antibiotic
cecropin Awith those of the bee venom toxin melittin produces
substantially improved activities over the parent structures [19],
show high bactericidal, antiendotoxic, fungicidal and leishma-
nicidal activities, both in vitro [20,21] and in vivo [22–24]. We
have also found that CA(1–8)M(1–18), an analogue where the
first eight residues of cecropin A are followed by the first
eighteen from melittin, induces expression of NOS2 in the
murine macrophage line RAW 264.7 in the absence of any
previous priming by LPS or cytokines [25]. This effect is
accompanied by a rise in intracellular Ca2+ concentration
immediately after peptide addition and prevented by the
presence of EGTA in the incubation media, ruling out Ca2+
release from intracellular stores. Since the all-d enantiomer of
CA(1–8)M(1–18) retains this activity, the involvement of a
specific receptor was excluded and plasma membrane perme-
ation validated as the most likely cause. The hypothesis wasfurther supported by the fact that the peptide permeated
zwitterionic liposomes mimicking the plasma membrane com-
position of higher eukaryotes [26].
In order to gain further insight into the early steps of the
CA(1–8)M(1–18)-RAW 264.7 interaction, we have used a
combination of patch-clamp, membrane permeation and con-
focal microscopy techniques. Our results support a process of
transient depolarization of the macrophage plasma membrane,
without significant cytotoxicity, as the driving force for this in-
direct mechanism of defense, and suggest new, unexpected roles
for CA(1–8)M(1–18) modulation of the immune response.
2. Materials and methods
2.1. Reagents
Chemicals of the best available quality were purchased from Sigma (St.
Louis, MO) and Fluka (Buchs, Switzerland). Bisoxonol, [bis-(1,3-diethylthio-
barbituric) trimethine oxonol], SYTOX\ green, and CFSE [5-(and-6) carboxy-
fluorescein diacetate succinimidyl ester] were from Molecular Probes (Leiden,
The Netherlands). Peptides were synthesized by the solid phase method [27]
using Fmoc chemistry [28], purified by reverse-phase HPLC (purity >95%) and
characterized by amino acid analysis and MALDI-TOF mass spectrometry. A
fluorescent analogue of CA(1–8)M(1–18) was made by N-terminal extension
with 6-aminohexanoic acid to which fluorescein was coupled.
2.2. Plasmids
The vectors piNOS2luc and pNF3ConA-luc have been described [29,30].
Both encode the Photinus pyralis luciferase gene as reporter, under the
control of either the 5 proximal flanking region of the murine promoter for
NOS2 (piNOSLuc [29]), or of a promoter containing three copies of the nB
consensus from the immunoglobulin kappa-chain promoter (pNF3ConA-luc)
[30]. Both plasmids were kindly provided by Prof. Manuel Fresno (Center for
Molecular Biology CSIC, Madrid Spain).
2.3. Cell culture
RAW 264.7 cells were cultured in RPMI 1640 (Gibco, BRL, Gaithes-
burg, MD) supplemented with 10% heat inactivated fetal calf serum (HIFCS)
(Gibco, BRL), l-glutamine (2 mM), gentamicin (30 Ag/mL) and penicillin
(100 IU/mL) (Sigma). Cultures were passed every 3 to 5 days and cells were
detached by a brief trypsin treatment, visualized in an inverted microscope.
Cells for patch-clamp experiments were removed from the dish with a rubber
policeman, a procedure that left the vast majority of cells intact. The cell
suspension was stored at room temperature (21–23 -C) and used within 6 h.
2.4. Cell transfection
The RAW 264.7 cells were transfected according to supplier’s (GIBCO,
BRL, Paisley, UK) instructions. Briefly, two 50 AL aliquots of lipofectin
(3% v/v) and the respective plasmid (0.15 Ag) in RPMI 1640 were separately
preincubated at 24 -C, gently mixed and incubated for 15 min at 24 -C. The
mixture was added to the cells (400 AL, 1.5106 cells/mL in RPMI 1640
without serum, 6 h, 37 -C, 5% CO2). Upon transfection, cells were washed,
resuspended in RPMI 1640+10% HIFCS and transferred into a 24-well
microplate. After overnight incubation, the medium was replaced with an
identical amount containing the respective concentration of CA(1–8)M(1–18)
or, as a positive control, LPS from Salmonella typhimurium (Sigma) at a final
concentration of 1 Ag/mL. Finally, the cells were incubated for an additional 24
h. Luciferase activity was evaluated by the Luciferase Assay System (Promega
Biotech, Barcelona, Spain) after lysis of the cells using the regents included in
the kit. Measurements were taken every 30 s in a TD-20/20 luminometer (Turner
Design, Sunnyvale, CA). Values were expressed as the fold increase relative to
cells in the absence of stimuli.
Fig. 1. Depolarization of RAW 264.7 cells by CA(1–8)M(1–18). Peptide was
added to cells (105 cells/well) at the concentrations shown at the right of the
respective trace, in the presence of 0.1 AM bisoxonol, and increase in
fluorescence (kexc=544 nm, kem=584 nm) was monitored. Arrows indicate
addition of peptide (t =0). Figure is representative of three other experiments
performed independently.
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Two sets of complementary experiments were carried out: plasma membrane
permeation to the vital dye SYTOX\ green, and depolarization. In both cases,
RAW 264.7 cells were harvested, washed, and resuspended in RPMI-1640+2%
HIFCS, transferred into 96-well microplates (5104 cells/well), and allowed to
adhere overnight. Afterwards, cells were washed three times with 300 AL of
Hanks+Glc through pipette aspiration. To assess membrane permeation to the
vital dye, 100 AL of 2 AMSYTOX\ green in Hanks+Glc were added to the well,
and the dye fluorescence monitored in a Polarstar Galaxy microplate reader
(BMG Labotechnologies, Offenburg, Germany), equipped with 485 and 520 nm
filters as excitation and emission wavelengths, respectively. Once the fluores-
cence value reached stabilization, 100 AL of peptide solution in Hanks+Glc were
added (final peptide concentrations 0.1–15 AM), and changes in fluorescence
monitored. Complete permeation was defined as that obtained after addition of
Triton X-100 at 0.05%. Experiments were carried out in triplicate at 37 -C.
A similar protocol was followed to assess RAW 264.7 plasma membrane
depolarization [31]. Once the cells were washed as above, 100 AL of 0.2 AM
bisoxonol in Hanks+Glc were added. Cells were incubated for an additional
25 min to allow dye equilibration, and 100 AL of the peptide solution were
then added. Increase in fluorescence (kexc=544 and kem=584 nm) due to
dye insertion into the hydrophobic matrix of the membrane once
depolarized, was monitored in a Polarstar Galaxy fluorescence microplate
reader at 37 -C.
2.6. Binding of fluoresceinated CA(1–8)M(1–18) to RAW 264.7 cells
Cells were plated at 5104 cells/well in a 96-well microplate and allowed
to adhere for 12 h, then incubated in Hanks+Glc for 4 h in the presence of 0.5
AM fluoresceinated CA(1–8)M(1–18) at 37 -C. Non-bound peptide was
washed with 1 mL of Hanks medium, cells were solubilized by addition of SDS
(final concentration 0.1%) and fluorescence measured in a Polarstar Galaxy
microplate reader (kexc=494 nm, kem=599 nm). The number of bound
molecules was calculated according to a standard curve of the fluoresceinated
CA(1–8)M(1–18). For confocal microscopy, the protocols were identical
except that the cells were seeded in a 8 multiwell chamber slide system (Nunc
GmbH, Wiesbaden, Germany). After incubation with the peptide and further
washing, cells were observed in a Leica TCS-SP2-AOBS-UV confocal
microscope equipped with inverted optics (Leica DMIRE2) with excitation at
482 nm and emission at 519 nm. Three-dimensional reconstruction was carried
out using the Leica confocal software v. 2.5.
2.7. CFSE labeling of RAW 264.7 cells
Cells were plated as above and incubated with 9 AM CFSE for 30 min at
37 -C [32]. The non-incorporated dye was removed by flushing the well with
Hanks+Glc, and observed at the confocal microscope with the same settings
than for fluoresceinated CA(1–8)M(1–18).
2.8. Electrophysiological technique and data acquisition
The intracellular pipette filling solution contained: 80 mM aspartate, 50
mM KCl, 3 mM phosphocreatine, 10 mM KH2 PO4, 3 mM MgATP, 10 mM
HEPES, 5 mM EGTA, and was adjusted to pH 7.25 with KOH. The bath
solution contained: 130 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2,
10 mM HEPES, and 10 mM d-glucose. The pH was adjusted to a final value of
7.40 with NaOH. Recordings were made with an Axopatch 200A patch-clamp
amplifier (Axon Instruments, Foster City, CA) using the whole-cell configu-
ration of the technique [33]. Currents were recorded at room temperature (21–
23 -C) at a stimulation frequency of 0.1 Hz, and sampled at 2 kHz after anti-
alias filtering at 1 kHz. Data acquisition and command potentials were
controlled with the use of pClamp 6.0.1. (Axon Instruments). The average
pipette resistance was 2.1T0.5 MV (n =14). Gigaohm seal formation was
achieved by suction (10T1 GV, n =15). Capacitive surface area and access
resistance were 4.6T0.6 pF (n =14) and 6.6T0.5 MV (n =14), respectively.
Usually, 80% compensation of the effective access resistance was obtained,which led to a mean uncompensated access resistance of 5.6T0.6 MV (n =14).
Since maximum current amplitudes averaged 0.8T0.2 nA (n =1 4), no
significant voltage errors (<5 mV) were expected with this experimental
setting. Microcal Origin 7.05 (Microcal Software, Northampton, MA), the
clampfit utility of the pClamp 6.0.1. program and custom made programs
were used to perform least-squares fitting and for data presentation.
2.9. Statistical analysis
Data are presented as mean valuesTS.D. Mean values in control conditions
and in the presence of peptide for a single variable were compared by paired
Student’s t test. One-way ANOVAwas used to compare more than two groups.
Statistical significance was set at P <0.05.
3. Results
3.1. Plasma membrane permeabilization of RAW 264.7 cells by
CA(1–8)M(1–18)
In order to analyze the membrane-permeating effects of
CA(1–8)M(1–18), two different but related parameters were
measured.
First, we analyzed the depolarization carried out by the
peptide, monitored by the increase in fluorescence of the
potential-sensitive dye bisoxonol, as this parameter is directly
related to the maintenance of ionic gradients across the plasma
membrane, hence highly susceptible to changes in permeability
to monovalent ions. CA(1–8)M(1–18) caused a fast and
concentration-dependent depolarization on RAW 264.7 cells
(Fig. 1). At CA(1–8)M(1–18) concentrations between 0.1 and
0.5 AM, an initial rise in the fluorescence of the potential-
sensitive dye bisoxonol was observed, followed by a partial
reversion towards the initial values, with an extent and a
recovery time inversely proportional to peptide concentration.
A full and irreversible depolarization, suggestive of permanent
membrane damage, was only observed at peptide concentra-
tions higher than 15 AM.
Fig. 3. NF-nB and NOS2 promoter activity in RAW 264.7 cells incubated with
CA(1–8)M(1–18). The activity of luciferase as reporter gene was measured in
two separate sets of RAW cells (6105 cells/well), lipofected either with the
expression vector piNOSLuc, encoding luciferase under the proximal region of
the murine promoter for NOS2 (white bars), or with pNF3ConA—where the
promoter of luciferase contains three copies of the nB consensus from the
immunoglobulin kappa-chain promoter (gray bars). The stimuli for luciferase
expression are shown at the abscissa: Control, unstimulated cells; Peptide,
CA(1–8)M(1–18) (plain bars) or its all-d-enantiomer (hatched bars); standard
inducer, LPS, 1 Ag/mL. The results were normalized with respect to luciferase
activity of untreated cells (control) with TS.D.
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cytotoxicity, the influx of the cationic vital dye SYTOX\ green
(MW=900) into the cytoplasm was monitored. This dye
permeates cells with damaged plasma membrane, not intact
organisms, and binds to intracellular nucleic acids with an
enhancement of its fluorescence [34]. For CA(1–8)M(1–18) at
concentrations above 0.2 AM (Fig. 2), such an increase in
fluorescence was observed in a dose-dependent manner, though
it never reached the full permeation levels achieved with 0.05%
Triton X-100. For any given peptide concentration, once the
respective maximal fluorescence value was reached, it
remained constant, in contrast with the partial reversal noted
above for bisoxonol at low-medium peptide concentrations.
This is because SYTOX\ fluorescence involves high affinity
binding to nucleic acids, amounting to practical irreversibility,
whereas bisoxonol insertion into the membrane hydrophobic
matrix is dynamic and reversible. Taken together, these results
evidenced that below 2 AM the peptide induced a transient,
concentration-dependent membrane depolarization. These tran-
sitory lesions might allow some SYTOX molecules to gain
access to the intracellular milieu.
3.2. Induction of NF-jB and NOS2 by CA(1–8)M(1–18 ) in
RAW 264.7 cells
In a previous work, we described the induction of NOS2
expression in RAW 264.7 caused by CA(1–8)M(1–18). In
order to link this effect to those concerning plasma membrane
permeation, we independently transfected two set of cells with
two expression vectors, each encoding luciferase as reporter
gene, either under a murine NOS2 promoter, or with one
containing three nB sites, whereby its activation became highly
dependent on the NF-nB activation. Under these conditions,Fig. 2. Permeation of RAW 264.7 cells to the vital dye SYTOX\ green caused
by addition of CA(1–8)M(1–18). Peptide was added to cells (105 cells/well) in
the presence of 1 AM SYTOX\ green in PBS + 20 mM d-glucose and the
increase in fluorescence (kexc=485 nm, kem=520 nm) monitored. Control
cells: solid squares. Peptide CA(1–8)M(1–18): 0.1 AM, empty circles; 0.2 AM,
solid triangles; 0.5 AM, empty diamonds; 0.7 AM, empty squares, 1.0 AM, solid
circles; 2.0 AM, empty triangles. First and second arrows stand for peptide and
0.05% Triton X-100 addition, respectively. Figure is representative of three
other experiments performed independently.luciferase expression induced by CA(1–8)M(1–18) or its all-
d-enantiomer paralleled that of NOS2. The expression of
luciferase, measured at three peptide concentrations, is shown
in Fig. 3. At 0.5 AM, the concentration causing the maximal
NOS2 expression with minimal toxicity, the expression of
luciferase, under NOS2 or nB promoter respectively, was 2.2
(T0.3) and 1.4 (T0.3)-fold higher than the unstimulated control
cells. In agreement with previous data [25], the induction of
these genes was always lower than that caused by 1 Ag/mL of
LPS: 4.9 (T0.8) and 1.9 (T0.3)-fold higher relative to
unstimulated cells. Interestingly, the all-d-enantiomer of
CA(1–8)M(1–18) caused a similar or even a slightly higher
activity than an all-l-amino acid synthetic peptide, ruling out
the involvement of a chiral receptor (Fig. 3). At this range of
peptide concentrations, the maximal inhibition of RAW 264.7
was less than 15% of the control cells.
3.3. Binding of fluoresceinated CA(1–8)M(1–18) to RAW
264.7
The fluoresceinated CA(1–8)M(1–18) analogue showed a
concentration-dependent accumulation into RAW 264.7 cells.
After 4-h incubation, the number of peptide molecules bound
per RAW 264.7 cell was (7.7T1.2)106, (15.6T2.3)106,
and (37.4T3.9)106 at 0.5, 1.5 and 4 AM, respectively. In a
kinetics experiment, the maximal level of fluorescence was
always observed during the initial 5 min, regardless of the
concentration assayed (data not shown).
Fig. 4. Confocal microscopy of RAW 264.7 cells labeled with fluoresceinated CA(1–8)M(1–18). Cells were plated as above and incubated with 0.5 (A), 1.5 (B)
and 4.0 AM (C) fluoresceinated CA(1–8)M(1–18) for 4 h at 37 -C. Cells were observed in a Leica TCS-SP2-AOBS-UV confocal microscope equipped with
inverted optics (kexc=482 nm and kem=519 nm). Peptide binding stoichiometry was 7.7 (T1.2)106, 15.6 (T2.3)106, and 37.4 (T3.9)106 molecules/cell at
0.5, 1.5 and 4 AM, respectively. Scale bar=4 Am.
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(1–18) appeared as small patches (Fig. 4), and completely
different from the more homogenous pattern obtained upon
labeling the cells with CFSE, a passive membrane-permeable
fluorescein derivative that reacts with amine groups, including
intracellular ones [35]. Three-dimensional single cell image
reconstruction by composition of serial confocal sections
through the z axis showed a staining of the irregular surface
of the macrophages by fluoresceinated CA(1–8)M(1–18),
rather than the more uniform distribution achieved by CFSE
labeling, which includes the intracellular space (see Supple-
mental material).Fig. 5. Endogenous currents recorded in RAW 264.7 cells after applying different p
Pulse protocol used to record outward delayed rectifier currents. (C) Pulse protoco3.4. Electrophysiological effects of CA(1–8)M(1–18) on RAW
264.7 cells
In order to get a deeper insight into the plasma membrane
permeation described in the previous subsections, we analyzed
the ion currents of RAW 264.7 cells in the presence of 0.5 AM
CA(1–8)M(1–18). We choose this concentration since it
produced maximal depolarization and expression of NOS2
yet minimal cytotoxicity. Under basal conditions, RAW 264.7
cells only exhibited an inward rectifying current and an
outward current (Figs. 5A and 5B). After applying pulse
protocols used to activate either Ca2+ or Na+ channels (200 msulse protocols. (A) Pulse protocol used to record inward rectifying currents. (B)
l used to record Na+ current. (D) Pulse protocol used to record Ca2+ current.
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+50 mV in 10 mV steps, respectively), no current with such
electrophysiological characteristics was recorded (Fig. 5C and
D), in agreement with data previously described [36–38].
Therefore, the experiments were carried out after applying
ramps from 100 mV to +140 mV (24 mV/s) in order to record
the overall cell current. Fig. 6 shows the current generated
under such pulse protocols in the absence and in the presence
of 0.5 AM CA(1–8)M(1–18). In the absence of the peptide, an
inward current was observed, followed by an outward one with
a mean amplitude value of 797.5T244.3 pA (n =6). In less than
1 min after cell perfusion with 0.5 AM CA(1–8)M(1–18), the
cell conductance increased dramatically (Fig. 6). After 10 min,
the recorded currents saturated the amplifier. These effects
were observed upon continuous perfusion of the cells with
CA(1–8)M(1–18). However, as depicted in Fig. 7, once cell
perfusion stopped, the amplitude of the current decreased, to
increase again upon re-start of peptide flux. This reversibility
was in full agreement with the previous results on plasma
membrane potential variation.
The effects caused by CA(1–8)M(1–18) may be due either
to a very high increase of the endogenous currents, or to
unspecific membrane permeation. In order to discern between
these two possibilities, we compared the outward and inward
currents in the absence and the presence of CA(1–8)M(1–18),
by using pulse protocols that activate these currents. Fig.
8 shows the current recorded in the absence and in the presence
of 0.5 AM CA(1–8)M(1–18). It can be seen that these two
currents were not modified by the peptide, thus suggesting that
CA(1–8)M(1–18) effects are not due to an increase of any of
these two endogenous currents, but to unspecific membrane
permeation. In fact, Triton X-100 (a non- specific permeation
agent) at 0.01% induced qualitatively similar effects as 0.5 AM
CA(1–8)M(1–18) (Fig. 9). The fact that CA(1–8)M(1–18)
effects can be attributed to unspecific membrane permeation
rather than to a specific effect on a given ion channel may beFig. 6. Effects of CA(1–8)M(1–18) on the current–voltage relationship
obtained in control conditions and in the presence of 0.5 AM peptide. Pulse
protocol, shown on the top panel, consists in a ramp from 100 mV to +140
mV. Holding potential was maintained at 80 mV.
Fig. 7. Variation in the currents recorded in RAW 264.7 cells in the absence and
in the presence of CA(1–8)M(1–18) under different perfusion conditions.
Panel A: Pulse protocol, shown on the top panel, consisted in a ramp from
100 mV to +140 mV. Holding potential was maintained at 80 mV. Records
were obtained in the absence and in the presence of 0.5 AM CA(1–8)M(1–18)
under continuous perfusion of external peptide solution. The bottom panel
shows a ramp obtained in the presence of CA(1–8)M(1–18) under continuous
perfusion and after stopped flow (without perfusion). Panel B: Variations in
current amplitude vs. time of a representative experiment. During this period,
control conditions (at the beginning), perfusion with CA(1–8)M(1–18), and
stop of perfusion are indicated by arrows.easily fit into two of the currently accepted models of
membrane permeation by EAPs, namely the carpet-like and
the two-state or worm-hole mechanisms [4].
4. Discussion
In the present work, we report the electrophysiological and
permeating effects of CA(1–8)M(1–18), a synthetic cecropin
Fig. 8. Effects of CA(1–8)M(1–18) on the endogenous currents of RAW 264.7 cells. Current records obtained in the absence and in the presence of the peptide
after applying a pulse protocol that activates an inward current (A) or a delayed outward current (B). Holding potential was maintained at 80 mV in both
experiments.
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murine macrophage cell line. The peptide produced a significant
variation in the levels of expression of some murine macro-
phage genes [25,40], including the induction of NOS2 in the
absence of any other stimuli [25]. The signal transduction
pathways involved in this process have been only partiallyFig. 9. Effects of Triton X-100 (0.01%) on the current recorded in RAW 264.7
cells. Pulse protocol, shown on the top panel, consisted in a ramp from 100
mV to +140 mV. Holding potential was maintained at 80 mV. Note that the
detergent induces an effect qualitatively similar to that of CA(1–8)M(1–18).mapped, i.e., there is an increase in the levels of intracellular
Ca2+ after peptide addition, and activation of the NF-nB
pathway is essential to the process [25]. As these effects were
reproducible with the all-d enantiomer, this strongly suggested
membrane permeabilization as an early step in NOS2 induction,
which is studied in detail in the present work. Despite minor
quantitative differences between our earlier results [25] and the
present ones, our original conclusions remain unaltered.
Once the reproducibility of the results was ensured, we
examined the early steps underlying the process. Our results
show that CA(1–8)M(1–18) causes an non–selective but
transitory permeation of the RAW 264.7 plasma membrane to
ions at 0.5 AM, the optimal concentration for depolarization of
RAW 264.7 and NOS2 induction with minimal toxicity [25,41].
This was evidenced by the electrophysiological effects induced
by CA(1–8)M(1–18) on RAW 264.7 cells: macrophage
permeability ceased when the flux of the peptide solution into
the perfusion chamber was stopped. Similar conclusions were
drawn in depolarization experiments, although in this case the
peptide was added as a single dose rather than in a continuous
flow. At low-medium peptide concentrations, a fast initial and
partially reversible depolarization was observed, of an extent
directly related to peptide concentration. The time and degree of
the repolarization of the plasma membrane was inversely related
to the dose of peptide, and above 2.0 AM the damage became
largely irreversible.
The pattern of the electrophysiological effects of CA(1–8)M
(1–18) on RAW 264.7 fitted with an unspecific ionic
C. Arias et al. / Biochimica et Biophysica Acta 1763 (2006) 110–119 117permeabilization rather than with the involvement of specific
channels. CA(1–8)M(1–18) at 0.5 AM induced an increase in
membrane conductance that disappeared when the flow was
stopped. One may conclude from this that CA(1–8)M(1–18)-
induced membrane perturbation, including Ca2+ entrance into
the cytoplasm [25] evidenced by the above mentioned increase
in cell conductance, is directly responsible for macrophage
activation. This is further supported by our finding that NOS2
induction by CA(1–8)M(1–18) and LPS required ionic fluxes
through the plasma membrane of the macrophage, though the
effects and mechanisms for either compound differed widely.
First, the level of NOS2 induction by the peptide was
consistently lower than those obtained with LPS or inflamma-
tory cytokines. One must therefore conclude that, under
physiological conditions, the antiendotoxic effect of the
peptide, which is known to preclude LPS binding to the
CD14 receptor [42], will prevail over any small NOS2
induction it may cause, with a final-anti inflammatory outcome
[43–45]. Secondly, the ionic fluxes required for NOS2
induction by LPS involve voltage-specific potassium channels,
mainly Kv1.3 and Kir2.1, whose expression level varies after
LPS binding to the corresponding Toll receptor [37]. In
contrast, the mild induction of NOS2 by CA(1–8)M(1–18)
was achieved by unspecific perturbation of the macrophage
plasma membrane, most likely by stoichiometric interaction of
the peptide with the phospholipids of the outer leaflet. This
NOS2 induction is reproducible with the all-d (enantiomeric)
peptide, [37,46] and endowed with a poor modulation,
evidenced by the narrow concentration gap between the
NOS2 induction and the trigger of apoptosis. In fact, the
outward currents induced by CA(1–8)M(1–18) in RAW 264.7
cells were qualitatively similar to those induced by Triton X-
100, a detergent that permeabilizes the cell membrane, thus
suggesting an activation of RAW 264.7 cells following an
unspecific membrane permeation, possibly similar to that
proposed for other membrane-active EAPs, such as human h-
defensin 3 on Xenopus oocytes [13]. Changes in the ionic
condition of the extracellular medium, such as low pH, have
also been described as inducers of NOS2 expression in rat
macrophages [47].
Our results substantiate the unspecific permeation by an
EAP of a higher eukaryotic cell, a fact that somehow
challenges the earlier assumption of an exclusive specificity
of action of these antibiotic peptides on pathogens. Indeed, a
variety of EAPs have been described as capable of affecting
different classes of cells sharing a common receptor, with
promotion of chemotaxis, angiogenesis and immune differen-
tiation [8]. Interestingly, unspecific permeation by EAPs of
diverse amphibian and mammalian cells has been also reported
[12–14], sometimes underlying a physiological function such
as the IL-1h processing [18], or induction of vascular
permeability by neutrophils [17]. The induction of NOS2
expression on RAW 264.7 by CA(1–8)M(1–18) [25], a
peptide capable of inducing permeability on zwitterionic
liposomes [26], fits into this category. However, there are
significant differences between the permeation processes for
liposomes and macrophages. First, permeation of RAW 264.7cells required continuous perfusion with the peptide to
maintain its effect, whereas for zwitterionic liposomes a single
dose of CA(1–8)M(1–18) caused an increasing and irrever-
sible leakage of the intracellular contents of the liposome.
Secondly, while for liposomes there were no significant
differences in the release of dyes of broadly different sizes
[26], in the macrophage the extent of plasma membrane
permeation differed widely between monovalent ions (i.e.,
depolarization) and the MW 900 SYTOX\ green dye.
These differences clearly suggest that CA(1–8)M(1–18)
may act through different permeabilization mechanisms. Thus,
for zwitterionic liposomes, a carpet-like mechanism was
proposed [26] where release of vesicle content was caused by
reversible but productive temporary distortions in phospholipid
packing. However, as the CA(1–8)M(1–18) interaction with
the zwitterionic bilayer was of low affinity, the process was
reversible and allowed the peptide to interact with other
liposomes. In contrast, in the present patch-clamp and
depolarization experiments on macrophages, this effect of
recurring permeabilization was absent, as permeabilization
stopped with the peptide supply. This might result from peptide
degradation by trypsin-like proteinases from the macrophage,
but seems somewhat unlikely since supplementing the peptide
solution with 5 Ag/mL of trypsin inhibitor did not alter the
situation (data not shown). Alternatively, it can be explained by
a permeabilization mechanism based on the worm-hole or two-
state model [48,49]. Under this hypothesis, permeabilization is
achieved by formation of mixed peptide–phospholipid transient
pores of variable stoichiometry that deactivate spontaneously,
distributing peptide monomers at both sides of the membrane.
This model will account for the reversibility of the permeabi-
lization and depolarization effects, as well as for the fact that an
influx of fresh peptide is required to maintain permeabilization.
The adoption of either model is highly dependent on additional
factors such as the complexity of biological vs. model
membranes, or the existence of a membrane potential in the
macrophage, but not in liposomes, that favors formation and
stabilization of the membrane-spanning pore [50]. In fact, even
with model planar membranes containing acidic phospholipids
more prone to be permeated by cationic peptides, a membrane
potential was needed to set off permeation by CA(1–8)M(1–18)
(named CEME in that particular work [51]).
Assuming that the worm-hole mechanism underlies the
effects observed on macrophages, an intrinsic consequence of
pore deactivation would be the translocation into the cytoplasm
of peptide molecules that could gain access to intracellular
targets. Since the all-d CA(1–8)M(1–18) enantiomer repro-
duces the effect, this hypothesis can be ruled out. In fact, the
three-dimensional distribution of fluoresceinated CA(1–8)
M(1–18) is quite different from that of CFSE, which also labels
the cytoplasm (see Supplemental material). The binding
stoichiometry of the fluoresceinated peptide at 0.5 AM, that
concentration providing optimal effect/toxicity ratio, was es-
timated as 7106 molecules/cell. For melittin, permeability to
Na+ in human red blood cells was achieved at 2104 molecules/
cell [52]. Correcting for the differences in area between human
erythrocytes and macrophages (120 and 1300 Am2, respectively;
C. Arias et al. / Biochimica et Biophysica Acta 1763 (2006) 110–119118[53]), the density of melittin molecules required for permeabi-
lization would be 2105 molecules/cell. Therefore, a peptide
density at least 30-fold higher is required for NOS2 induction by
CA(1–8)M(1–18) than for erythrocyte permeabilization by
melittin. This estimation fully agrees with the lower cytotoxicity
of CA(1–8)M(1–18) relative to melittin [39].
As mentioned in Introduction, modulation of the immune
cells by unspecific permeation by EAPs was recently described
for LL-37 on IL-1h processing in macrophages [18]. Neverthe-
less, the in vivo toxic effects of these peptides will be strongly
modulated by their short life in serum, either by degradation by
proteinases or through their binding to serum proteins [39,54–
56], as well as by interaction with anionic components of the
membrane, mainly glycosaminoglycans [57]. In fact, a complete
lack of toxicity was described for cecropin A–melittin peptides,
such as the CA(1–7)M(2–9) hybrid, when applied as a colirium
against experimental ocular keratitis in rabbits [23], or of its
acylated analogue, Na-octanoyl-CA(1–7)M(2–9), adminis-
tered by intravenous injection in Leishmania-infected dogs
[24]. Experiments are in progress in order to define whether
NOS2 induction was solely due to variation of ionic gradients
across the membrane or to the release of intracellular mediators,
as described for IL-1 processing driven by LL-37 [18].
In conclusion, our results demonstrate immune cell modu-
lation by EAPs or their analogues causing unspecific but limited
permeation of the plasma membrane, in contrast with modula-
tion through EAP–receptor interaction as described for the
defensins [7]. The importance of the macrophage in the
modulation of the immune response against a wide variety of
pathogens, plus the fact that CA(1–8)M(1–18) can activate this
cell to express nitric oxide, a lethal metabolite for a wide variety
of pathogens, even in the absence of other cytokines, open new
therapeutic perspectives for these peptides aside from their
permeation of pathogen surfaces.
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